Oncology

Dual HPV and LBC testing 'has no additional impact'

Combining human papillomavirus (HPV) testing with routine liquid-based cytology (LBC) screening does not increase cervical cancer detection rates, a new UK study has indicated.

Ethnicity and wealth factors 'influence cancer screening trends'

A new study has indicated that wealth and ethnicity are linked to whether UK women have regular breast and cervical screenings.

Fear 'affects women's cervical cancer screening decision'

A new report has indicated that fear plays a major role in whether women decide to go for cancer screening or not.

Cancer risk 'lower for UK women than men'

Women in the UK are much less likely to die of cancer than men, a new study has indicated.

Cervical cancer jabs receives WHO approval

The World Health Organization (WHO) has granted pre-qualification status to a four-type human papillomavirus (HPV) vaccine, it has been announced.

Men 'unwilling to protect female partners from cervical cancer'

Women could be put at increased risk of cervical cancer because their male partners are unwilling to help cut the dangers, according to a new study.

Cervical cancer vaccine 'could protect older women'

Millions of women could benefit from having a vaccine to protect them from developing cervical cancer, a new study has indicated.

UK cancer survival rates 'improving'

A huge improvement in adult cancer survivorship has been witnessed in the last three decades, it has been claimed.

Programme launched to reduce global cancer deaths

The World Health Organization (WHO) has joined forces with the International Atomic Energy Agency (IAEA) to strengthen and accelerate efforts to fight cancer in the developing world.

Women 'reluctant to discuss genetic testing' as cancer precaution

A new study has found that few women with family histories of breast or ovarian cancer are discussing genetic testing with their physicians.